Clinical Trial: 21253

Trial Status: Open
Disease Type: Gynecologic
Trial ID 21253
Sponsor ID FLORA-5

A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma(FLORA-5)

Principal Investigator
Robert L. Marsh, MD
3 Locations

Locations

Arlington Office

Fairfax Office

Gainesville Office

Learn More About This Trial

Other Relevant Trials
Trial ID 21457
Sponsor ID Artistry-7

(ALKS 4230-007/GOG-3063) A Phase 3, Multicenter, Open-Label, Randomized Study of Nemvaleukin Alfa in Combination With Pembrolizumab Versus Investigator’s Choice Chemotherapy in Patients With Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARTISTRY-7)

Principal Investigator
Robert L. Marsh, MD
5 Locations
Trial ID 21369
Sponsor ID PICCOLO

PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression

Principal Investigator
Robert L. Marsh, MD
3 Locations